Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Post by SABBOBCATon Feb 14, 2023 3:02pm
301 Views
Post# 35285865

Valentine's Ball

Valentine's Ball

What are floks feeling about seeing Thera's linkein post about Paul, Dawn, and Dale all attending the Valentine's Ball? I dont have any issue with the cause or the support, but as an investor it is a little frustrating to see the CEO, Chair, and a boardmember all out galavanting while we have been waiting for an update. I know they all have lives and there is nothing stopping them from this, however actively posting about the ball comes across as tonedeaf when considering the share price is in the gutter. 

For me this adds to the tealeaves that they have some good news to share in the near future, or else it may spell the end of the 'fudiciary' responsibilities of the shareholder representatives come the AGM. 

What the news is remains a mystery. Could it be a partner? a deal? an FDA green light on a revised protocol? who knows?

<< Previous
Bullboard Posts
Next >>